Group
Rare Diseases
4 themes21 tickers
10D rank#31of 142 groups
Peek into the magic of rare disease healthcare. Our group splits into gene, RNA, and protein therapy themes, plus CNS/neuro breakthroughs. With supportive policies and expanding patient access, this market is buzzing with innovative platforms and growth.
Themes in this group
Build 20260824T084825
| Rare Diseases '25: Platform Biotechs & Pipelines | 4 | $29.93B | $119.74B | -1.13% | +4.12% | +10.03% | +11.80% | +30.72% | +83.07% | +113.08% | +255.36% | +19.57% | +27.82% | +26.43% | +109.62% | +5.90% | +8.13% |
| Rare Diseases '25: Gene Therapy & Genetic Med | 7 | $3.96B | $27.72B | +1.00% | +3.96% | +7.54% | +11.64% | +37.28% | +57.82% | +21.52% | +6.95% | +0.92% | +20.84% | +35.48% | +55.23% | +3.29% | +6.83% |
| Rare Diseases '25: CNS/Neuro | 5 | $31.16B | $155.82B | +0.08% | +0.84% | +2.72% | +9.63% | +38.52% | +96.36% | +23.98% | +139.11% | +8.95% | +24.82% | +19.68% | +107.99% | +0.44% | +14.19% |
| Rare Diseases '25: RNA Therapy & Protein Mod | 5 | $11.94B | $59.68B | +0.66% | -1.21% | +8.47% | +11.80% | -9.98% | +25.64% | +12.97% | +316.91% | +9.09% | +4.43% | +0.39% | +68.67% | +12.69% | -1.09% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary